Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,792
  • Shares Outstanding, K 24,152
  • Annual Sales, $ 2,020 K
  • Annual Income, $ -17,590 K
  • 60-Month Beta 0.55
  • Price/Sales 1.83
  • Price/Cash Flow N/A
  • Price/Book 1.30
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.15 +3.29%
on 10/30/19
0.58 -72.88%
on 10/22/19
-0.29 (-65.11%)
since 10/11/19
3-Month
0.15 +3.29%
on 10/30/19
1.40 -88.79%
on 08/20/19
-0.54 (-77.57%)
since 08/09/19
52-Week
0.15 +3.29%
on 10/30/19
1.40 -88.79%
on 08/20/19
-0.59 (-79.07%)
since 11/09/18

Most Recent Stories

More News
iBio, Inc. Prices $5,000,000 Public Offering

IBIO, INC. (NYSE AMERICAN: IBIO) ("IBIO" OR THE "COMPANY"), today announced the pricing of an underwritten public offering with expected total gross proceeds of approximately $5,000,000, before deducting...

IBIO : 0.16 (unch)
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

IBIO, INC. (NYSE AMERICAN: IBIO) ("IBIO" OR THE "COMPANY") announced today that on October 16, 2019, the Company received notice from NYSE American (the "Exchange") that the Company currently is below...

IBIO : 0.16 (unch)
iBio's Collaboration with South Africa's AzarGen Biotechnologies Advances to Next Stage

iBio, Inc. (NYSE AMERICAN:IBIO) ("iBio" or the "Company") today announced that it has entered into the initial Statement of Work ("SOW1") under its Memorandum of Understanding ("MOU") with AzarGen Biotechnologies...

IBIO : 0.16 (unch)
Thinking about buying stock in Canopy Growth, Ibio, Momo, Micron Technology, or Ossen Innovation?

InvestorsObserver issues critical PriceWatch Alerts for CGC, IBIO, MOMO, MU, and OSN.

CGC : 20.30 (-5.41%)
IBIO : 0.16 (unch)
MU : 46.26 (-1.97%)
MOMO : 38.80 (unch)
iBio and CC-Pharming Expand Business Collaboration in China

iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has expanded the scope of its business venture with CC-Pharming Ltd. by granting it an exclusive, royalty-bearing commercial license to iBio's bio-better...

IBIO : 0.16 (unch)
Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus?

InvestorsObserver issues critical PriceWatch Alerts for APA, CNHI, HD, IBIO, and VVUS.

APA : 23.85 (-2.37%)
CNHI : 11.23 (-0.09%)
HD : 231.80 (-0.45%)
IBIO : 0.16 (unch)
VVUS : 2.75 (-5.82%)
iBio Inks 3D Bioprinting Agreement

iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has entered into a Master Services Agreement ("MSA") with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ:UTHR),...

IBIO : 0.16 (unch)
UTHR : 90.96 (-0.71%)
CLGN : 4.25 (+4.94%)
iBio Announces Appointment of Thomas F. Isett to Board of Directors

iBio, Inc. (NYSE AMERICAN:IBIO), a biologics contract manufacturer and product developer with proprietary, "green" technologies for biopharmaceutical production, today announced the appointment of Thomas...

IBIO : 0.16 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade IBIO with:

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

2nd Resistance Point 0.18
1st Resistance Point 0.17
Last Price 0.16
1st Support Level 0.15
2nd Support Level 0.14

See More

52-Week High 1.40
Fibonacci 61.8% 0.92
Fibonacci 50% 0.78
Fibonacci 38.2% 0.63
Last Price 0.16
52-Week Low 0.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar